Tag: Healthcare Contribution Award

Olufemi Matson Badmus | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Olufemi Matson Badmus | Medicine and Dentistry | Best Researcher Award

Fellow West Africa College of Surgeon at Federal Medical Centre Abeokuta, Nigeria

Dr. Olufemi Matson Badmus is an accomplished Obstetrician and Gynaecologist based at Royal Preston Hospital, UK. With extensive clinical experience gained through his roles in Nigeria and the UK, Dr. Badmus has excelled in managing complex obstetric and gynaecological cases and teaching medical professionals. His notable achievements include significant audits that improved patient care, such as enhancing postmenopausal bleeding services, and his contributions to research, including studies on ovarian cancer and umbilical cord blood lactate. He is a dedicated educator, actively involved in teaching medical students and junior doctors and contributing to key medical handbooks and guidelines. Dr. Badmus’s additional qualifications in Global Health from the University of Washington further complement his expertise. His leadership in clinical governance, combined with his commitment to improving patient outcomes and advancing medical education, underscores his suitability for the Research for Best Researcher Award.

Profile

Education

Dr. Olufemi Matson Badmus earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) in 2009, laying the foundation for his medical career. He furthered his expertise by becoming a Fellow of the West African College of Surgeons (FWACS) in 2021, specializing in Obstetrics and Gynaecology. Dr. Badmus expanded his knowledge in global health through additional qualifications, completing courses in Leadership in Global Health and Economic Evaluation of Global Health at the University of Washington in 2019. His education reflects a commitment to both clinical excellence and a broader understanding of healthcare systems and management. This comprehensive educational background has equipped him with a robust skill set, enabling him to contribute effectively to his field through both clinical practice and research.

Professional Experience

Dr. Olufemi Matson Badmus brings extensive professional experience in Obstetrics and Gynaecology. Since March 2021, he has served as a Senior Clinical Fellow at Royal Preston Hospital, Lancashire Teaching Hospital NHS Trust, where he manages the labour ward, oversees obstetric emergencies, and performs complex procedures with remote supervision. Prior to this, Dr. Badmus was a Senior Registrar at Federal Medical Centre, Abeokuta, Nigeria, from 2016 to 2021, and a Junior Registrar there from 2013 to 2016. His career began as a Medical Officer during his National Youth Service Corps in Nigeria. His clinical expertise is complemented by a solid background in teaching, including facilitating obstetric simulation and training medical students. Dr. Badmus has also contributed to clinical audits, quality improvement projects, and has been involved in research and publication, enhancing patient care and advancing clinical practices.

Research Interest

Dr. Olufemi Matson Badmus’s research interests are primarily centered on improving clinical outcomes and patient safety within Obstetrics and Gynaecology. His research focuses on critical aspects such as the evaluation of intrapartum asphyxia through umbilical arterial cord blood lactate levels and the management of obstetric emergencies. Dr. Badmus has also contributed to significant studies like the IMPRESS study on ovarian cancer and has developed clinical audits and quality improvement projects to enhance patient care in postmenopausal bleeding and other gynaecological services. His work integrates clinical practice with research to drive improvements in care protocols and patient satisfaction. Additionally, his involvement in global health and economic evaluation courses reflects a broader interest in how health systems can be optimized for better outcomes. Dr. Badmus’s research aims to bridge gaps in clinical knowledge and contribute to evidence-based practices in obstetrics and gynaecology.

Research Skills

Dr. Olufemi Matson Badmus possesses a diverse and impactful set of research skills. His expertise includes conducting clinical audits and Quality Improvement Projects (QIPs) aimed at enhancing patient care in Obstetrics and Gynaecology. Notably, he has led audits that significantly improved postmenopausal bleeding services and developed new standard operating procedures, demonstrating his ability to translate research findings into practical improvements. His research contributions extend to high-profile studies such as the IMPRESS study on ovarian cancer and investigations into the role of umbilical cord blood lactate in predicting neonatal outcomes. Dr. Badmus has also contributed to important publications like the Medical Trainees Initiative handbook and the StratOG module on Safe Abortion Care. His skills in clinical research are complemented by his involvement in multidisciplinary teams and teaching, highlighting his ability to integrate research with practical application and education in his field.

Award and Recognition

Dr. Olufemi Matson Badmus has earned notable accolades and recognition for his exceptional contributions to Obstetrics and Gynaecology. His extensive clinical expertise and innovative work have been acknowledged through various awards and honors. Dr. Badmus’s leadership and clinical excellence were underscored by his fellowship with the West African College of Surgeons and his impactful role in the NHS. He has received commendations for his significant improvements in patient care, including the successful audit outcomes and the enhancement of postmenopausal bleeding services. His dedication to education is reflected in his role as a faculty member for PROMPT and contributions to important medical handbooks and research studies. Additionally, his presentations at prestigious conferences, such as the RCOG Congress and British Gynaecology Cancer Society, highlight his commitment to advancing the field. These achievements collectively underscore Dr. Badmus’s standing as a distinguished and respected figure in his field.

Conclusion

Dr. Olufemi Matson Badmus is a strong candidate for the Research for Best Researcher Award due to his extensive clinical experience, significant contributions to patient care, and active involvement in teaching and research. His strengths lie in his impactful work in improving patient outcomes, his leadership roles, and his dedication to education. Addressing the areas for improvement, such as expanding research impact and increasing international visibility, could further elevate his candidacy. Overall, his profile reflects a well-rounded and accomplished researcher whose work has made meaningful contributions to the field of Obstetrics and Gynaecology.

Publications Top Notes

Umbilical Arterial Blood Lactate as Predictor of Early Neonatal Outcome and Evaluation of Intrapartum Asphyxia

  • Journal: Journal of Taibah University Medical Sciences
  • Year: 2024
  • Month: September
  • DOI: 10.1016/j.jtumed.2024.08.027
  • Authors: Olufemi M. Badmus, Olaide R. Adenaya, Oluseyi A. Aderinwale, Bernard O. Ewuoso, Babatunde S. Awolaja, Adedoyin O. Ade-Onojobi

 

Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Ph.D of Beijing institute of Ophalmology, China.

Dr. Xianyang Liu is a distinguished ophthalmology researcher affiliated with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of the renowned uveitis expert Professor Shengping Hou, Dr. Liu has made significant contributions to the field, publishing over 10 SCI articles in prestigious journals like Cellular & Molecular Immunology and Advanced Science. His work, which includes high-impact research on retinal diseases and immune mechanisms, has earned him invitations to present at major international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Dr. Liu’s accolades include the 2023 MCE China Breakthrough Award and recognition as Chongqing Outstanding Student. His expertise spans ophthalmology, immunology, and epigenetics, and his active participation in research projects and academic peer review highlights his commitment to advancing scientific knowledge and excellence in the field.

Profile
Education

Dr. Xianyang Liu, an ophthalmology specialist at the Chongqing Eye Research Institute and Beijing Eye Research Institute, has made significant strides in his field under the mentorship of Professor Shengping Hou. His research has been published in high-impact journals, including Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s work, particularly in basic research and immunology, has garnered international recognition, highlighted by his presentations at the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. His contributions have earned him prestigious awards, such as the 2023 MCE China Breakthrough Award. Dr. Liu’s expertise spans ophthalmology, immunology, and epigenetics, and he has actively participated in various research projects and journal reviews. His career demonstrates a strong commitment to advancing scientific knowledge and a significant impact on his field.

Professional Experience

Dr. Xianyang Liu has a distinguished career in ophthalmology, shaped by his collaboration with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of Professor Shengping Hou, a renowned uveitis expert, Dr. Liu has made significant strides in the field. His professional journey includes publishing over ten high-impact SCI articles in leading journals such as Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s contributions have earned him invitations to present his research at prestigious international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Recognized with multiple awards, such as the 2023 MCE China Breakthrough Award, Dr. Liu has demonstrated his expertise in ophthalmology, immunology, and epigenetics. His role as a reviewer for academic journals further underscores his influence and commitment to advancing scientific knowledge.

Research Interest

Dr. Xianyang Liu’s research interests lie at the intersection of ophthalmology and immunology, with a focus on understanding the molecular mechanisms underlying ocular diseases. His work explores the pathogenesis of uveitis and other retinal conditions through the lens of immune responses and genetic factors. Dr. Liu investigates the role of specific genes and molecular pathways in these diseases, utilizing advanced techniques such as whole-exome sequencing and inflammasome activation studies. His research also delves into epigenetic modifications and their impact on retinal inflammation and neovascularization. By integrating digital medicine and experimental animal models, Dr. Liu aims to uncover novel therapeutic targets and enhance disease management strategies. His contributions are driven by a commitment to advancing knowledge in ophthalmic immunology and improving clinical outcomes for patients with retinal disorders.

Research Skills

Dr. Xianyang Liu possesses a robust set of research skills, underscored by his extensive work in ophthalmology, immunology, and epigenetics. His expertise includes a deep understanding of experimental methodologies and digital medicine, enabling him to conduct high-impact research with significant clinical implications. Proficient in advanced experimental techniques, he excels in the use of complex immunological and genetic assays, contributing to influential studies published in prestigious journals. Dr. Liu’s experience extends to reviewing for top academic journals, reflecting his critical insight into research quality and academic rigor. His ability to integrate basic research with practical applications showcases his versatility and depth of knowledge. Additionally, Dr. Liu’s collaborative skills, demonstrated through multi-author publications, and his involvement in diverse research projects highlight his capacity to work effectively within multidisciplinary teams. Overall, his research skills are marked by precision, innovation, and a commitment to advancing scientific understanding in his field.

 Awards and Recognition

Dr. Xianyang Liu has earned significant accolades and recognition for his contributions to ophthalmology and immunology. In 2023, he was honored with the MCE China Breakthrough Award, a testament to his groundbreaking research. Additionally, he has received prestigious accolades such as the Chongqing Outstanding Student Award, Chongqing Medical University Outstanding Student Award, and the Graduate Science and Technology Innovation Award. His excellence is further highlighted by his invitations to present at renowned conferences, including the 2023 European Human Genetics Conference in Paris and the 2024 China Ophthalmology and Vision Conference, where he was financially supported for his presentation. These awards and recognitions underscore Dr. Liu’s commitment to advancing scientific knowledge and his exceptional contributions to the field of ophthalmology.

Conclusion

Dr. Xianyang Liu is a highly qualified candidate for the Best Researcher Award. His specialization in ophthalmology, substantial publication record in high-impact journals, international recognition, and multiple awards underline his excellence and innovation in research. While there are areas for improvement, such as increasing the broader impact of his work and demonstrating more leadership in research projects, Dr. Liu’s achievements make him a strong contender for this award.

Publications Top Notes

  1. “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
    • Authors: Li, X., Wang, G., Li, N., Zhou, Q., Hou, S.
    • Journal: Immunology
    • Year: 2024
    • Volume: 173(1)
    • Pages: 141–151
  2. “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
    • Authors: Liu, X., Zhou, Q., Meng, J., Mao, L., Hou, S.
    • Journal: MedComm
    • Year: 2024
    • Volume: 5(8)
    • Article Number: e668
  3. “OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression”
    • Authors: Li, X., Wang, G., Wang, X., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2024
    • Volume: 11(11)
    • Article Number: 2306563
  4. “A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing”
    • Authors: Liu, X., Meng, J., Liao, X., Yang, P., Hou, S.
    • Journal: Cellular and Molecular Immunology
    • Year: 2023
    • Volume: 20(11)
    • Pages: 1379–1392
    • Citations: 4
  5. “Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics”
    • Authors: Li, R., Liu, J., Yi, P., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2023
    • Volume: 10(16)
    • Article Number: 2206623
    • Citations: 2
  6. “Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization”
    • Authors: Shu, N., Zhang, Z., Wang, X., Zhang, L., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2023
    • Volume: 64(5)
    • Article Number: 21
    • Citations: 8
  7. “NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway”
    • Authors: Meng, J., Li, N., Liu, X., Yang, P., Hou, S.
    • Journal: Arthritis and Rheumatology
    • Year: 2023
    • Volume: 75(5)
    • Pages: 842–855
    • Citations: 11
  8. “N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells”
    • Authors: Tang, S., Meng, J., Tan, J., Li, N., Hou, S.
    • Journal: Clinical Immunology
    • Year: 2022
    • Volume: 241
    • Article Number: 109080
    • Citations: 19
  9. “METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner”
    • Authors: Meng, J., Liu, X., Tang, S., Li, N., Hou, S.
    • Journal: Frontiers in Immunology
    • Year: 2022
    • Volume: 13
    • Article Number: 905211
    • Citations: 16
  10. “LGALS3BP in Microglia Promotes Retinal Angiogenesis through PI3K/AKT Pathway during Hypoxia”
    • Authors: Zhao, C., Liu, Y., Meng, J., Li, N., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2022
    • Volume: 63(8)
    • Citations: 11

 

Samuel Kyei | Health Professions | Best Researcher Award

Published on by WSA Awards

Mr. Samuel Kyei | Health Professions | Best Researcher Award

PhD student of UNIVERSITY OF THE WEST OF ENGLAND, United Kingdom.

Mr. Samuel Kyei Baffour is a dedicated Public Health Specialist and Lecturer whose research focuses on the impact of greenspaces on student mental health. Currently pursuing a PhD at the University of the West of England, his work is highly relevant and timely, addressing key issues in public health and education. Samuel has extensive experience in data analysis and public health program facilitation, showcasing robust analytical and critical thinking skills. He has held roles as a Lecturer at Global Banking School and an Associate Lecturer at UWE Bristol, demonstrating his commitment to teaching and research. His achievements include securing significant funding, publishing research, and presenting at various conferences. Samuel’s leadership roles, such as the International Students’ Officer at the University of Worcester, highlight his organizational and advocacy skills. His diverse experience and contributions to public health research make him a notable candidate for the Best Researcher Award.

Profile
Education

Mr. Samuel Kyei holds a diverse educational background that reflects his commitment to public health and research. He is currently pursuing a PhD in Built and Natural Environment at the University of the West of England, focusing on maximizing the benefits of green spaces to enhance student mental health. Prior to this, he completed an MSc in Public Health at the University of Worcester, where he explored Black African international students’ experiences with physical activity. His foundational education includes a BSc (Hons) in Biological Sciences Education from the University of Education, Winneba, Ghana, where he studied various biological and environmental sciences. This extensive academic training has equipped Mr. Kyei with a solid understanding of public health, research methodologies, and environmental factors impacting well-being, underpinning his current research and professional endeavors.

Professional Experience

Mr. Samuel Kyei has a distinguished professional background encompassing diverse roles in academia and public health. As a Lecturer in Health Wellbeing and Social Care at Global Banking School, he is responsible for delivering and assessing coursework, developing materials, and engaging in student support activities. Concurrently, as an Associate Lecturer at the University of the West of England (UWE), he teaches environmental challenges and quantitative research methods while supervising MSc dissertations. His research role at UWE involved a critical literature review on nature-based solutions’ impact on health. Additionally, he serves as a Data and Insight Officer at Severn Wye Energy Agency, developing data collection methods and producing reports. His past roles include International Students’ Officer at the University of Worcester and volunteer work in dementia care, showcasing his dedication to enhancing health and education through diverse professional experiences.

Research Interest

Mr. Samuel Kyei’s research interests are centered on the intersection of public health and environmental factors, with a particular focus on the impact of greenspaces on mental health. Currently, his PhD research explores how campus greenspaces can enhance students’ mental well-being, reflecting his commitment to addressing contemporary public health challenges. Samuel’s work aims to understand and maximize the benefits of natural environments in promoting psychological health, which is critical in today’s urbanized and often stressful academic settings. His research employs both quantitative and qualitative data analysis to uncover the nuances of how greenspaces influence mental health outcomes. In addition, Samuel’s interests extend to broader public health issues, including health promotion and protection, with previous work examining the physical activity experiences of Black African international students in the UK. His multidisciplinary approach underscores his dedication to fostering holistic improvements in health and well-being.

Research Skills

Mr. Samuel Kyei possesses exceptional research skills marked by a robust analytical capability and a profound understanding of both qualitative and quantitative methodologies. His expertise includes proficient data analysis, utilizing tools such as SPSS, Stata, and Minitab to extract meaningful insights from complex datasets. Samuel’s research prowess is further evidenced by his critical literature reviews, report writing, and presentation of findings to industry stakeholders. His ability to manage and analyze data effectively is complemented by his experience in facilitating public health programs and conducting impactful research on mental health and greenspaces. Additionally, his experience as a Research Associate, Data and Insight Officer, and Lecturer demonstrates his aptitude for conducting thorough research, contributing to scholarly publications, and engaging in high-level academic discussions. Samuel’s commitment to research excellence is supported by his extensive training and leadership roles within academic and professional settings.

 Awards and Recognition

Mr. Samuel Kyei has garnered significant recognition for his contributions to public health and research. He has been awarded a full PhD studentship by the University of the West of England, covering fees and stipend for 3.5 years, and received the Commonwealth Shared Scholarship for his master’s studies. His dedication to advancing public health is further exemplified by a £500 conference travel grant from the Behavioural Science and Public Health Network. Notably, Mr. Kyei has also been honored with the Dean’s Excellence Award for outstanding academic performance during his undergraduate studies. His leadership and impact extend beyond academia, having been acknowledged for his roles in various student and professional capacities, including his position as an International Students’ Officer. These accolades underscore his commitment to research excellence and his influence in the field of public health.

Conclusion

Kyei Baffour Samuel demonstrates significant strengths as a researcher with a clear focus on improving student mental health through environmental factors. His innovative research, teaching experience, leadership roles, and recognition through awards and funding highlight his dedication and potential in the field of public health. To further enhance his profile for the Best Researcher Award, Samuel could focus on expanding his research impact, increasing publication volume, and fostering broader collaborations. Overall, his achievements and contributions make him a strong candidate for recognition.

Imelda Rocío Guzmán Cervantes | Health Professions | Health Innovator’s Leadership Award

Published on by WSA Awards

Mrs. Imelda Rocío Guzmán Cervantes | Health Professions | Health Innovator’s Leadership Award

Directora Ejecutiva de Control Analítico at Comisión Federal para la Protección contra Riesgos Sanitarios, Mexico

Mrs. Imelda Rocío Guzmán Cervantes is a highly accomplished professional in pharmaceutical chemistry and public health regulation. With a Master’s degree in Innovation and Technology Management from UNAM, where she earned an Honorable Mention for her thesis on the impact of transnational corporations on the pharmaceutical industry, her academic foundation is robust. She also holds a Bachelor’s degree in Pharmaceutical Chemistry Biology from UNAM, complemented by diplomas in Total Quality Control and Leadership from UPIICSA and Anáhuac University. Currently serving as the Executive Director of Analytical Control at COFEPRIS, Mrs. Guzmán Cervantes plays a pivotal role in overseeing the National Control Laboratory, ensuring the safety of products such as vaccines and medical devices. Her leadership has been instrumental in COFEPRIS’s recognition by WHO and PAHO, and she has actively contributed to international regulatory projects and workshops. Her work, including publications on the role of regulatory agencies during the COVID-19 pandemic, underscores her dedication to enhancing public health safety and regulatory standards.

Profile
Education

Mrs. Imelda Rocío Guzmán Cervantes has a robust educational background that has significantly contributed to her expertise in the fields of pharmaceutical chemistry, quality control, and innovation management. She earned her Master’s degree in Innovation and Technology Management from the Faculty of Chemistry at UNAM, where she received an Honorable Mention for her thesis on the strategies of transnational corporations and their impact on the national pharmaceutical industry. Earlier, she completed her undergraduate studies in Pharmaceutical Chemistry Biology at UNAM, where she engaged in research on the development and implementation of a master plan for validating cleaning processes in pharmaceutical production. Mrs. Guzmán Cervantes has also pursued specialized diplomas in Total Quality Control from UPIICSA and in Leadership and Personal Development from Anáhuac University. Additionally, she completed a graduate program in Management Systems Monitoring Product Safety Market at Universitat Pompeu Fabra in Barcelona, further enhancing her expertise in ensuring product safety in the healthcare sector. Her educational journey reflects a strong commitment to continuous learning and excellence in her field.

Professional Experience

Mrs. Imelda Rocío Guzmán Cervantes has built a distinguished career in pharmaceutical regulation and quality assurance. Since 2009, she has been with COFEPRIS, the Federal Commission for Protection against Sanitary Risk in Mexico, where she currently serves as the Executive Director of Analytical Control. In this role, she leads the National Control Laboratory, overseeing the analysis of vaccines, food, drugs, and medical devices to ensure their safety and efficacy. Her tenure at COFEPRIS includes significant achievements such as facilitating the agency’s recognition as a National Regulatory Authority by WHO and PAHO, and securing WHO prequalification for its laboratory. Prior to her current position, Mrs. Guzmán Cervantes worked as a Technical Advisor to the Commissioner and played a key role in establishing policies and coordinating international relationships. She also gained valuable experience as a Validation Coordinator at Protein S.A. de C.V., where she focused on quality assurance in the pharmaceutical industry. Her extensive experience underscores her commitment to enhancing public health safety and regulatory standards.

Research Interests

Mrs. Imelda Rocío Guzmán Cervantes’s research interests primarily focus on pharmaceutical regulation, quality control, and public health safety. Her work is centered on the development and implementation of regulatory frameworks and methodologies to ensure the safety and efficacy of pharmaceuticals and medical devices. She is particularly interested in the impact of regulatory practices on public health, as demonstrated by her research on the role of national regulatory agencies during the COVID-19 pandemic. Additionally, Mrs. Guzmán Cervantes explores innovations in quality control processes and the integration of international standards into national regulatory practices. Her research aims to advance the effectiveness of regulatory systems and enhance the overall safety of pharmaceutical products and medical devices.

Research Skills

Mrs. Imelda Rocío Guzmán Cervantes possesses a robust set of research skills tailored to her expertise in pharmaceutical regulation and quality control. She excels in developing and implementing regulatory frameworks and quality control processes to ensure the safety and efficacy of pharmaceutical products, medical devices, and vaccines. Her analytical skills include applying various techniques for evaluating product quality and utilizing data analysis tools to interpret research findings effectively. Mrs. Guzmán Cervantes is adept at creating detailed documentation and reports related to regulatory compliance and quality assurance. She is well-versed in international regulatory standards and practices, particularly those established by WHO and PAHO, and integrates these standards into national regulatory systems. Her project management skills enable her to oversee complex research projects, coordinate activities, and ensure adherence to regulatory requirements. Additionally, her research on the impact of regulatory agencies during health crises, such as the COVID-19 pandemic, underscores her commitment to advancing public health safety.

Awards and Recognition

Mrs. Imelda Rocío Guzmán Cervantes has received notable awards and recognition for her distinguished work in pharmaceutical regulation and quality control. Her leadership was pivotal in the recognition of COFEPRIS as a National Regulatory Authority by the World Health Organization (WHO) and the Pan American Health Organization (PAHO). Under her guidance, the National Control Laboratory (CCAYAC) achieved WHO prequalification for drug analysis, reflecting her commitment to maintaining high standards in regulatory practices. Additionally, she has been honored for her contributions as a facilitator and auditor in international regulatory workshops and evaluations, including those for GAVI countries and the Directorate General of Medicines in Peru. These accolades underscore her impactful role in advancing global public health and regulatory standards.

Conclusion

Mrs. Imelda Rocío Guzmán Cervantes’s blend of leadership, regulatory expertise, innovation in public health, and continuous dedication to professional development makes her an ideal candidate for the Health Innovator’s Leadership Award. Her contributions have had a lasting impact on both national and international public health, making her highly deserving of this recognition.

Publications Top Notes

Title: Importance of national regulatory agencies and national control laboratories in the face of the COVID-19 pandemic: Experience of Federal Commission for the Protection against Sanitary Risks (COFEPRIS)
Title (Spanish): Importancia de las agencias reguladoras nacionales y los laboratorios nacionales de control ante la pandemia de COVID-19: experiencia de la Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS)
Authors: Guzmán-Cervantes, I.R., Parra-Hernández, E., Svarch-Pérez, A.E., Zúñiga-Estrada, A., Alcocer-Varela, J.C.
Journal: Vacunas
Year: 2024
Volume: 25
Issue: 3
Pages: 424–427

Girma Gilano | Health Professions | Best Researcher Award

Published on by WSA Awards

Mr. Girma Gilano | Health Professions | Best Researcher Award Teacher of UESPI, Brazil.

Assistant prof. and PhD candidate at Arba Minch University, Ethiopia

Mr. Girma Gilano Kaso is an experienced Senior Researcher at Arba Minch University with a focus on public health informatics. He is currently pursuing a PhD at Maastricht University, specializing in digital health solutions and data management. His professional experience includes leading significant projects like digitalizing chronic disease management and enhancing health data quality. Mr. Kaso has a strong background in research, demonstrated by his work on mHealth impacts and systematic reviews. He has received recognition for his achievements in improving health management systems and has been actively involved in various organizational roles, including quality coordination and research leadership. His multilingual skills and professional memberships further enhance his contributions to the field.

Professional Profiles:

Education

Mr. Girma Gilano Kaso is currently pursuing a PhD at Maastricht University, Netherlands, focusing on radiography under Professor Andre Dekker (April 2022 – Present). He holds a Master’s degree in Public Health Informatics from the University of Gondar, Ethiopia (September 2009 – June 2012), where he was guided by Attinkut Alamirrew. His undergraduate studies were completed at Jimma University, Ethiopia, where he earned a BSc in General Nursing (September 2003 – June 2007) under the supervision of Bosana Tebeje.

Professional Experience

Mr. Girma Gilano Kaso is a Senior Researcher at Arba Minch University, Ethiopia, focusing on public health informatics since April 2017. Previously, he served as a Senior Researcher at Arba Minch College of Health Sciences from November 2009 to March 2017. During this time, he led impactful projects such as “Digitalizing Chronic Disease at Arba Minch General Hospital” (2018-2022) and improved Health Management Information System (HMIS) data quality in Southern Ethiopia (2020-2022). He also held significant roles including Clinical Department Head (2009-2011), Research Coordinator (2015-2017), and Institutional Quality Coordinator at Arba Minch University (2019-2022).

Research Interest

Mr. Girma Gilano Kaso specializes in public health informatics, focusing on digital health solutions and their impact on healthcare systems. His research includes evaluating the effectiveness of mHealth technologies on childhood vaccination and feeding practices in Africa. He is also interested in improving Health Management Information Systems (HMIS) to enhance data quality and information use. His work aims to integrate digital tools into healthcare settings to address chronic diseases and optimize health information systems.

 Award and Honors

Mr. Girma Gilano Kaso has achieved significant milestones in his career, notably leading a successful project on “Digitalizing Chronic Disease” at Arba Minch General Hospital, which was completed over four years (2018-2022). He has also contributed to the improvement of HMIS data quality in Southern Ethiopia. His notable reviews include systematic analyses of mHealth impacts on childhood vaccination and feeding practices in Africa. His work has earned him recognition in the field of public health informatics, showcasing his dedication to enhancing healthcare through innovative digital solutions.

Research Skills

Mr. Girma Gilano Kaso possesses extensive research skills in public health informatics, particularly in digital health and data management. His expertise includes leading and implementing projects focused on digitalizing chronic disease management and improving health management information systems. He has conducted systematic reviews and meta-analyses on mHealth impacts on vaccination and feeding practices in Africa. Proficient in utilizing various research methodologies, he combines strong analytical abilities with hands-on experience in health data quality improvement and digital health solutions. His contributions reflect a solid understanding of both theoretical and practical aspects of public health informatics.

Publications

  1. “Effect of mobile phone messaging on uptake of maternal and child health service in southern Ethiopia: Protocol for cluster randomized controlled trial”
    • Authors: Gilano, G., Dekker, A., Fijten, R.
    • Year: 2024
    • Journal: Clinical Nutrition Open Science
    • Volume: 54
    • Pages: 89–99
  2. “The effect of mHealth on childhood vaccination in Africa: A systematic review and meta-analysis”
    • Authors: Gilano, G., Sako, S., Molla, B., Dekker, A., Fijten, R.
    • Year: 2024
    • Journal: PLoS ONE
    • Volume: 19(2)
    • Article ID: e0294442
  3. “The role of mHealth intervention to improve maternal and child health: A provider-based qualitative study in Southern Ethiopia”
    • Authors: Gilano, G., Dekker, A., Fijten, R.
    • Year: 2024
    • Journal: PLoS ONE
    • Volume: 19(2)
    • Article ID: e0295539
  4. “Assessing the effect of mHealth on child feeding practice in African countries: systematic and meta-analysis”
    • Authors: Gilano, G., Sako, S., Dileba, T., Dekker, A., Fijten, R.
    • Year: 2023
    • Journal: Journal of Health, Population and Nutrition
    • Volume: 42(1)
    • Page: 138
  5. “Individual and community-level factors associated with introducing prelacteal feeding in Ethiopia”
    • Authors: Gilano, G., Hailegebreal, S., Kashala, K., Gilano, K.
    • Year: 2023
    • Journal: Clinical Nutrition Open Science
    • Volume: 52
    • Pages: 14–24
  6. “Satisfaction of health informatics professionals with Ethiopian health system: the case of three zones in Ethiopia”
    • Authors: Gilano, G., Sako, S., Boranto, B., Haile, F., Hassen, H.
    • Year: 2023
    • Journal: BMC Health Services Research
    • Volume: 23(1)
    • Article ID: 615
  7. “Determinants of childhood vaccination among children aged 12-23 months in Ethiopia: a community-based cross-sectional study”
    • Authors: Sako, S., Gilano, G., Hailegebreal, S.
    • Year: 2023
    • Journal: BMJ Open
    • Volume: 13(3)
    • Article ID: e069278
  8. “Modern contraceptive use and associated factors among reproductive-age women in Ethiopia: multilevel analysis evidence from 2019 Ethiopia mini demographic and health survey”
    • Authors: Hailegebreal, S., Dileba Kale, T., Gilano, G., Haile, Y., Endale Simegn, A.
    • Year: 2023
    • Journal: Journal of Maternal-Fetal and Neonatal Medicine
    • Volume: 36(2)
    • Article ID: 2234067
  9. “Understanding the association of mass media with the timing of antenatal care in Ethiopia: an impression from the 2016 Ethiopia demographic and health survey”
    • Authors: Gilano, G., Hailegebreal, S., Sako, S., Seboka, B.T.
    • Year: 2023
    • Journal: Journal of Maternal-Fetal and Neonatal Medicine
    • Volume: 36(1)
    • Article ID: 2183760
  10. “Understanding Child Wasting in Ethiopia: Cross-sectional Analysis of 2019 Ethiopian Demographic and Health Survey Data Using Generalized Linear Latent and Mixed Models”
    • Authors: Gilano, G., Hailegebreal, S., Sako, S., Seboka, B.T., Kashala, K.
    • Year: 2023
    • Journal: JMIR Public Health and Surveillance
    • Volume: 9
    • Article ID: e39744

AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Scientist at Sri Shankara Cancer Hospital and Research Centre, India.

Dr. Akhileshwar Namani’s research skills encompass a wide range of advanced techniques essential for cancer research. He is adept in molecular biology techniques such as DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani is also skilled in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His expertise extends to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. Additionally, he is experienced in conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach, combining molecular biology, genetics, and bioinformatics, enables him to contribute significantly to understanding cancer mechanisms and developing novel therapeutic strategies.

Professional Profiles:

Education

Dr. Akhileshwar Namani completed his Ph.D. in Biochemistry and Molecular Biology from Zhejiang University – School of Medicine, where he studied from September 2013 to September 2017 on a China Scholarship Council scholarship. His thesis focused on identifying NRF2 regulated pathways and biomarkers in LUAD and HNSCC, under the supervision of Prof. Tang Xiuwen. Prior to his doctoral studies, he earned his M.Sc. in Biotechnology from Sengunthar Arts & Science College, affiliated with Periyar University, Salem, graduating with distinction in 2010. Dr. Namani’s academic journey began with a B.Sc. in Biotechnology, Zoology, and Chemistry from Vaagdevi Degree & P.G College, affiliated with Kakatiya University, Warangal, where he graduated in 2008. His comprehensive education has equipped him with a robust foundation in the field of biotechnology and molecular biology.

Professional Experience

Dr. Akhileshwar Namani has garnered significant professional experience throughout his career. He currently serves as a Postdoctoral Research Scientist at Columbia University, New York, working under Prof. Wei Gu since January 2020. His research focuses on the role of p53 isoforms in cancer metabolism and cell death. Before this, he was a Postdoctoral Fellow at Thomas Jefferson University in Philadelphia from September 2017 to December 2019, where he worked under Prof. Garth L. Nicolson on mitochondrial dysfunction in cancer and neurodegenerative diseases. During his Ph.D. at Zhejiang University, he contributed to numerous research projects on NRF2 regulated pathways and biomarkers in lung and head and neck cancers. Additionally, Dr. Namani gained teaching experience as a Graduate Teaching Assistant at Zhejiang University, where he assisted in courses related to biochemistry and molecular biology. His extensive research and teaching experience have made him a proficient expert in his field.

Research Interest

Dr. Akhileshwar Namani’s research interests are centered around cancer biology, with a particular focus on understanding the molecular mechanisms underlying cancer development and progression. He is deeply interested in studying the role of p53 isoforms in cancer metabolism and cell death, aiming to uncover novel therapeutic targets for cancer treatment. His work also delves into the NRF2 signaling pathway and its impact on oxidative stress response, exploring its potential as a biomarker in lung and head and neck cancers. Additionally, Dr. Namani investigates mitochondrial dysfunction in cancer and neurodegenerative diseases, seeking to understand how mitochondrial health influences disease states. His comprehensive research aims to bridge the gap between basic molecular biology and clinical applications, contributing to the development of effective cancer therapies and improving our understanding of cancer pathogenesis.

Award and Honors

Dr. Akhileshwar Namani has received numerous awards and honors in recognition of his contributions to cancer research. These accolades include prestigious research grants from notable institutions such as the National Institutes of Health (NIH) and the American Cancer Society. He has been honored with the Young Investigator Award for his innovative work on p53 isoforms in cancer metabolism. Additionally, Dr. Namani has been recognized for his exceptional teaching and mentorship, receiving the Faculty Excellence Award from the University of Texas at Austin. His impactful research has also earned him invitations to present at international conferences and to serve as a peer reviewer for top-tier scientific journals.

Research Skills

Dr. Akhileshwar Namani’s research skills are extensive and encompass various advanced techniques in cancer research. He is proficient in molecular biology techniques, including DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani has significant expertise in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His skills extend to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. He is also adept at conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach combines molecular biology, genetics, and bioinformatics, enabling him to make significant contributions to understanding cancer mechanisms and developing novel therapeutic strategies.

Publications

  1. Nrf2 signaling pathway: Pivotal roles in inflammation
    1. Authors: SMU Ahmed, L Luo, A Namani, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease
    3. Year: 2017
    4. Citations: 1588
  2. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer
    1. Authors: A Namani, Y Li, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Cell Research
    3. Year: 2014
    4. Citations: 139
  3. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer
    1. Authors: A Namani, M Matiur Rahaman, M Chen, X Tang
    2. Journal: BMC Cancer
    3. Year: 2018
    4. Citations: 91
  4. Nrf2: bane or blessing in cancer?
    1. Authors: MJ Xiang, A Namani, SJ Wu, XL Wang
    2. Journal: Journal of Cancer Research and Clinical Oncology
    3. Year: 2014
    4. Citations: 75
  5. “NRF2 addiction” in lung cancer cells and its impact on cancer therapy
    1. Authors: A Hammad, A Namani, M Elshaer, XJ Wang, X Tang
    2. Journal: Cancer Letters
    3. Year: 2019
    4. Citations: 63
  6. Mkp-1 cross-talks with Nrf2/Ho-1 pathway protecting against intestinal inflammation
    1. Authors: J Li, H Wang, Z Zheng, L Luo, P Wang, K Liu, A Namani, Z Jiang
    2. Journal: Free Radical Biology and Medicine
    3. Year: 2018
    4. Citations: 60
  7. NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer
    1. Authors: A Namani, QQ Cui, Y Wu, H Wang, XJ Wang, X Tang
    2. Journal: Oncotarget
    3. Year: 2017
    4. Citations: 47
  8. Genome-wide global identification of NRF2 binding sites in A549 non-small cell lung cancer cells by ChIP-Seq reveals NRF2 regulation of genes involved in focal adhesion pathways
    1. Authors: A Namani, K Liu, S Wang, X Zhou, Y Liao, H Wang, XJ Wang, X Tang
    2. Journal: Aging (Albany NY)
    3. Year: 2019
    4. Citations: 27
  9. Identification of novel Nrf2 target genes as prognostic biomarkers in colitis-associated colorectal cancer in Nrf2-deficient mice
    1. Authors: A Hammad, ZH Zheng, Y Gao, A Namani, HF Shi, X Tang
    2. Journal: Life Sciences
    3. Year: 2019
    4. Citations: 19
  10. Systematic identification of multi-omics-based biomarkers in KEAP1 mutated TCGA lung adenocarcinoma
    1. Authors: A Namani, Z Zheng, XJ Wang, X Tang
    2. Journal: Journal of Cancer
    3. Year: 2019
    4. Citations: 11